Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RBM25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RBM6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
PRPF38B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF207 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MALAT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
GABBR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101930343 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NFAM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DRD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MBNL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928343 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAH6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EIF3B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAQR6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC20A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AHSA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MMP25-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on